BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31521437)

  • 1. Reversal of angiotensin-(1-12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis.
    Li T; Zhang Z; Zhang X; Chen Z; Cheng HJ; Ahmad S; Ferrario CM; Cheng CP
    Int J Cardiol; 2020 Feb; 301():135-141. PubMed ID: 31521437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.
    Zhang X; Cheng HJ; Zhou P; Kitzman DW; Ferrario CM; Li WM; Cheng CP
    Int J Cardiol; 2017 Jun; 236():405-412. PubMed ID: 28096047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility.
    Li T; Zhang X; Cheng HJ; Zhang Z; Ahmad S; Varagic J; Li W; Cheng CP; Ferrario CM
    Int J Cardiol; 2018 Aug; 264():137-144. PubMed ID: 29685688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan restores the positive force-frequency relation in heart failure.
    Masutani S; Cheng HJ; Tachibana H; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H488-96. PubMed ID: 21572004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure.
    Ky B; French B; May Khan A; Plappert T; Wang A; Chirinos JA; Fang JC; Sweitzer NK; Borlaug BA; Kass DA; St John Sutton M; Cappola TP
    J Am Coll Cardiol; 2013 Sep; 62(13):1165-72. PubMed ID: 23770174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure.
    Cheng CP; Suzuki M; Ohte N; Ohno M; Wang ZM; Little WC
    Circ Res; 1996 May; 78(5):880-92. PubMed ID: 8620609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure.
    Masutani S; Cheng HJ; Morimoto A; Hasegawa H; Han QH; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H923-30. PubMed ID: 23873794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure.
    Zhou P; Cheng CP; Li T; Ferrario CM; Cheng HJ
    Ther Adv Cardiovasc Dis; 2015 Dec; 9(6):342-53. PubMed ID: 26082338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.
    Li T; Cheng HJ; Ohte N; Hasegawa H; Morimoto A; Herrington DM; Little WC; Li W; Cheng CP
    J Pharmacol Exp Ther; 2016 Jun; 357(3):545-53. PubMed ID: 27026682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure.
    Tachibana H; Cheng HJ; Ukai T; Igawa A; Zhang ZS; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H914-22. PubMed ID: 15486041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS; Hettrick DA; Warltier DC
    Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desflurane, sevoflurane, and isoflurane impair canine left ventricular-arterial coupling and mechanical efficiency.
    Hettrick DA; Pagel PS; Warltier DC
    Anesthesiology; 1996 Aug; 85(2):403-13. PubMed ID: 8712457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
    Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M
    J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure.
    Onishi K; Ohno M; Little WC; Cheng CP
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1214-22. PubMed ID: 10027861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading.
    Chemaly ER; Chaanine AH; Sakata S; Hajjar RJ
    J Appl Physiol (1985); 2012 Oct; 113(8):1267-84. PubMed ID: 22923502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload.
    Gladden JD; Zelickson BR; Guichard JL; Ahmed MI; Yancey DM; Ballinger S; Shanmugam M; Babu GJ; Johnson MS; Darley-Usmar V; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1440-50. PubMed ID: 24014679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms.
    Zhang X; Li T; Cheng HJ; Wang H; Ferrario CM; Groban L; Cheng CP
    Life Sci; 2021 Nov; 285():119955. PubMed ID: 34520767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.